Toprol XL
RSS
AstraZeneca plans to cut 3,000 jobs
Feb 2 2007, Rahul Bhandari

AstraZeneca, UK based pharmaceutical plan to cut 3,000 jobs, or 4.6 percent of its global work force, after battling competition from generic manufacturers for its key heart drug Toprol XL.

AstraZeneca said the job cuts over three years would...

Related Stories
Most Recent Most Popular Most Commented
(0)
Report: Drug sales down in US, slower elsewhere
AP, Trenton
Pharmaceutical sales, squeezed by the worldwide recession, will increase globally by the slowest rate in a quarter-century and decline in the U.S. this year, according...
Drugs, Outlook, Business, Pharmaceutical
made popular Apr 22 2009
(0)
Correction: KV Pharmaceutical recall
AP, St. Louis
In a Jan. 28 story about KV Pharmaceutical Co., The Associated Press erroneously described Toprol XL as an antidepressant. It is used to treat hypertension and angina.
KV, Pharmaceutical, Recall, CORRECTIVE
made popular Jan 29 2009
(0)
Experts expect hurdles, but closing of Pfizer buy
AP, Trenton
Pharmaceutical giant Pfizer Inc.’s plan to buy rival Wyeth is likely to go through, experts said Wednesday, but the $68 billion purchase _ Pfizer’s third...
Pfizer, Wyeth, Acquisition, Business
made popular Jan 28 2009
(0)
Pfizer agrees to buy Wyeth for $68 billion
AP, New York
Pharmaceutical giant Pfizer Inc. is buying rival drugmaker Wyeth in a $68 billion cash-and-stock deal that could reshape the drug development industry.
Pfizer, Wyeth, Acquisition, Business
made popular Jan 26 2009
(0)
Pharma to Democrats: We're here to help
AP, Washington
After years of bitter disagreement with Democrats, the pharmaceutical industry’s top lobbyist said Wednesday he is ready to work with the party as it assumes...
Pharmaceutical, Lobby, Democrats, Business
made popular Jan 14 2009
(0)
Bayer sues Abbott, alleging patent infringement
AP, Trenton
Pharmaceutical and chemical maker Bayer AG has filed a federal lawsuit alleging that drugmaker Abbott Laboratories’ best-selling drug, Humira, infringes on a...
Bayer, Abbott, Lawsuit, Business
made popular Dec 30 2008
(0)
Bayer to increase R&D spending above euro2.8B
AP, Frankfurt
Pharmaceutical and chemical maker Bayer AG said Friday the company would increase its research and development spending above the current euro2.8 billion ($3.75...
EU, Germany, Bayer, Business
made popular Dec 12 2008
(0)
KV Pharma CEO leaves on uncertain terms
AP, New York
The chief executive of drugmaker KV Pharmaceutical Co. is leaving under disputed circumstances, as Marc Hermelin says he informed the company of his retirement Monday,...
KV, Pharmaceutical, Personnel, Business
made popular Dec 5 2008
(0)
AstraZeneca to cut jobs, close plants in Europe
AP, London
Pharmaceutical company AstraZeneca PLC said Thursday it plans to close three plants in Spain, Belgium and Sweden and cut 1,400 jobs in Europe by 2013 to improve...
EU, Britain, AstraZeneca, Jobs
made popular Nov 20 2008
(0)
FDA approves generic version of Astra asthma drug
AP, London
Pharmaceutical company AstraZeneca PLC said Wednesday that its rival Teva Pharmaceutical Industries Ltd. has been granted approval by the U.S. Federal Drug...
EU, Britain, AstraZeneca, Business
made popular Nov 19 2008
(0)
AstraZeneca receives approval for bipolar drug
AP, London
Pharmaceutical company AstraZeneca PLC said Thursday European regulators have approved a new version of its bipolar disorder drug Seroquel.
EU, Britain, AstraZeneca, Business
made popular Nov 13 2008
(0)
AstraZeneca 3Q profits up 29 percent
AP, London
Pharmaceutical company AstraZeneca PLC posted a 29 percent rise in third quarter net profit on Thursday as strong sales in emerging markets like China helped offset...
EU, Britain, Earns, AstraZeneca
made popular Oct 30 2008
(0)
Novartis to buy Nektar's pulmonary unit for $115M
AP, Basel
Pharmaceutical giant Novartis AG said Tuesday it will buy the pulmonary drug unit of California-based Nektar Therapeutics for $115 million.
EU, Switzerland, Novartis, Nektar
made popular Oct 21 2008
(0)
Abbott Laboratories 1Q profit surges 35 pct on global sales
AP, Chicago
Pharmaceutical company Abbott Laboratories Inc. said Wednesday that its first-quarter earnings surged 35 percent, driven by robust international sales of its rheumatoid...
Earns, Abbott, Laboratories, Business
made popular Apr 16 2008
(0)
Researchers see through a Crystal clear and Stronger Glass
Pankaj, Shimla
Look at your window - look at the glass of your window to be exact. Though the window glass looks clear, if you could peer inside the pane you would see a surprising...
Glasses, Crystal, traditional glass, medical applications
made popular Dec 8 2006
(0)
IT Outsourcing and Pharmaceutical Industry
Gautam, Dehradun
A number of drug companies don’t have any plans of increasing the level of sales and marketing IT which they would outsource over the next three to five years...
pharmaceutical, outsourcing, insourcing, Business
made popular Sep 21 2006
(0)
Drug ads from the past
Balendu, Delhi
This blog has a fantastic collection of classic ads from pharmaceuticals companies. The print dominated medium of advertising was the only effective tool during 50s and...
Pharmaceutical, Drug Ads, Business
made popular Jul 14 2006
(0)
New organic gel nanomaterials used to encapsulate pharmaceutical, food, cosmetic products
Irani, New Delhi
Organic gel nanomaterials! Scientists have created this new material and can be used for encapsulating pharmaceutical, food, and cosmetic products. It can also help...
organic gel, nanomaterials, organic gel nanomaterials, pharmaceutical
made popular Jun 30 2006
All Stories
Most Recent Most Popular Most Commented
(0)
Correction: KV Pharmaceutical recall
AP, St. Louis
In a Jan. 28 story about KV Pharmaceutical Co., The Associated Press erroneously described Toprol XL as an antidepressant. It is used to treat hypertension and angina.
KV, Pharmaceutical, Recall, CORRECTIVE
made popular Jan 29 2009
Related Tags
AstraZeneca Business corrective KV KV Pharmaceutical Associated Press Pfizer pharmaceutical recall
FAQ / Help
Move to top